805122
PLGA microspheres
50 μm average diameter
Synonym(s):
Degradex® PLGA, PLGA Nanoparticles
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
(C3H4O2)x(C2H2O2)y
NACRES:
NA.23
UNSPSC Code:
12162002
form
powder
average diameter
50 μm
density
1.3 g/cm3
storage temp.
−20°C
General description
Degradex® is made with poly(D,L-lactide-co-glycolide) with an L/G ratio of 50/50 and a Mw of 30,000.
To re-constitute:
To re-constitute:
- Remove the product from freezer.
- Wait until temperature rises to the ambient temperature.
- Add DI water or buffer to the container.
- Vortex and sonicate for 5 minutes to ensure the microspheres are well suspended.
Application
Plain PLGA particles for testing system compatibility in drug delivery research. Particles can be used as carriers by attaching drug or biological/chemical entities to particle surface. PLGA particles are used for controlled release, sustained release and targeted drug delivery.
Legal Information
Degradex is a registered trademark of Phosphorex, Inc.
Still not finding the right product?
Explore all of our products under PLGA microspheres
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Biomaterials science integrates smart materials into biological research, requiring a deep understanding of biological systems.
Study on how Degradex® PLGA microspheres and nanoparticles can be used for drug delivery research and formulation development.
Polymeric antioxidants show promise in drug delivery with superior bioavailability and antioxidant potential.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 805122-50MG | 04061832979830 |